Cel-Sci (United States)

Recent papers from Cel-Sci (United States)

1. A novel neoadjuvant immunotherapy confers improved overall survival in oral cancer patients with low tumor PD-L1 expression The IT-MATTERS Clinical trial – Prognostic role of tumor PD-L1 expressionOral Oncology · 2026
2. Neoadjuvant leukocyte interleukin injection immunotherapy improves overall survival in low-risk locally advanced head and neck squamous cell carcinoma –the IT-MATTERS studyPathology & Oncology Research · 2025
3. Current status of immunological therapies for rheumatoid arthritis with a focus on antigen-specific therapeutic vaccinesFrontiers in Immunology · 2024
4. Vaccine Immunomodulation of Disease: Targeting the Treatment of Autoimmune DiseasesMedical Research Archives · 2022
5. Restoring the Balance between Pro-Inflammatory and Anti-Inflammatory Cytokines in the Treatment of Rheumatoid Arthritis: New Insights from Animal ModelsBiomedicines · 2021
6. Vaccination by Two DerG LEAPS Conjugates Incorporating Distinct Proteoglycan (PG, Aggrecan) Epitopes Provides Therapy by Different Immune Mechanisms in a Mouse Model of Rheumatoid ArthritisVaccines · 2021
7. Why Don't We Have a Vaccine Against Autoimmune Diseases? - A Review.2019
8. Considerations and Issues in the Utilization of Infrared Thermography for Concrete Bridge Inspection at Normal Driving SpeedsJournal of Bridge Engineering · 2017
9. An epitope-specific DerG-PG70 LEAPS vaccine modulates T cell responses and suppresses arthritis progression in two related murine models of rheumatoid arthritisVaccine · 2017
10. LEAPS Vaccine Incorporating HER-2/neu Epitope Elicits Protection That Prevents and Limits Tumor Growth and Spread of Breast Cancer in a Mouse ModelJournal of Immunology Research · 2017
11. J-LEAPS vaccines elicit antigen specific Th1 responses by promoting maturation of type 1 dendritic cells (DC1)AIMS Allergy and Immunology · 2017
12. Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritisExpert Review of Vaccines · 2015
13. Antigen-activated dendritic cells ameliorate influenza A infectionsJournal of Clinical Investigation · 2013
14. LEAPS Therapeutic Vaccines as Antigen Specific Suppressors of Inflammation in Infectious and Autoimmune DiseasesJournal of Vaccines & Vaccination · 2012
15. J‐LEAPS peptide and LEAPS dendritic cell vaccinesMicrobial Biotechnology · 2011
16. A New Oil-Based Antigen Delivery Formulation for both Oral and Parenteral VaccinationThe Open Drug Delivery Journal · 2008
17. Design and Operational Performance of Double Crossover Intersection and Diverging Diamond InterchangeTransportation Research Record Journal of the Transportation Research Board · 2005
18. Design and Performance Analysis of Pedestrian Crossing Facilities for Continuous Flow IntersectionsTransportation Research Record Journal of the Transportation Research Board · 2005
19. The L.E.A.P.S. approach to vaccine developmentFrontiers in bioscience · 2005
20. Design and Operational Performance of Double Crossover Intersection and Diverging Diamond InterchangeTransportation Research Record Journal of the Transportation Research Board · 2005